Simplex Trading’s Foghorn Therapeutics FHTX Stock Holding History

Simplex Trading’s Portfolio FHTX Stock Details FHTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-700	Closed	-$3.78K	–	9399
2025 Q4	$3.78K	Buy	+700	New	+$3.17K	﹤0.01%	7569
2025 Q3	–	Sell	-400	Closed	-$1K	–	9347
2025 Q2	$1K	Sell	400 -500	-56%	-$2.09K	﹤0.01%	8313
2025 Q1	$3K	Buy	+900	New	+$4.1K	﹤0.01%	7806
2024 Q2	–	Sell	-200	Closed	-$1K	–	9075
2024 Q1	$1K	Buy	+200	New	+$1.11K	﹤0.01%	8560
2022 Q4	–	Sell	-200	Closed	-$1K	–	9532
2022 Q3	$1K	Buy	+200	New	+$2.57K	﹤0.01%	9528
2022 Q2	–	Sell	-500	Closed	-$7K	–	10286
2022 Q1	$7K	Sell	500 -62,200	-99%	-$854K	﹤0.01%	9161
2021 Q4	$1.43M	Buy	+62,700	New	+$901K	﹤0.01%	2407

Other funds holding FHTX

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Simplex Trading's FHTX Position: Q1 2026 in Review

Simplex Trading opened a new position in Foghorn Therapeutics (FHTX) in Q1 2026: 66 shares worth $315. The stake represents ﹤0.01% of the portfolio and ranks #8791 among its holdings. This is a return to the name: Simplex Trading previously reported a position in FHTX as recently as Q2 2025.

Simplex Trading first reported a position in FHTX in Q4 2021 and has held it in 8 quarters since. The position peaked at $126K in Q4 2021. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

Simplex Trading held 66 shares of Foghorn Therapeutics worth $315 as of Q1 2026.
Foghorn Therapeutics was a new Simplex Trading position in Q1 2026.
Foghorn Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8791 holding.
Simplex Trading first reported a position in Foghorn Therapeutics in Q4 2021 and has held it in 8 quarters since.
Simplex Trading's Foghorn Therapeutics position peaked at $126K in Q4 2021.
105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.